Clinical Research Directory
Browse clinical research sites, groups, and studies.
22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions
Sponsor: Huazhong University of Science and Technology
Summary
The investigators conduct a prospective, multicenter, blinded, randomized controlled trial to compare the diagnostic value and safety of the 22G Adapt needle versus the 22G Franseen needle for histopathological evaluation of solid lesions.
Official title: A Prospective, Multicenter, Blinded, Randomized Controlled Trial Assessing the Diagnostic Yield and Tissue Adequacy of 22G Adapt Versus 22G Franseen Fine-Needle Biopsy for Solid Lesions Under Endoscopic Ultrasound Guidance
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
576
Start Date
2025-07
Completion Date
2026-12-10
Last Updated
2025-07-01
Healthy Volunteers
No
Interventions
22G Franseen Needle Group
Fine-needle-biopsy (22G Franseen, Boston Scientific, Winston-Salem, USA)
22G Adapt Needle Group
Fine-needle-biopsy (22G Adapt, Micro.Tech Endoscopy, Nanjing, China)
Locations (1)
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China